ETON PHARMACEUTICALS, INC.

(ETON)
  Report
Delayed Nasdaq  -  05/20 04:00:00 pm EDT
3.260 USD   +2.19%
05/12TRANSCRIPT : Eton Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 12, 2022
CI
05/12ETON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
05/12Eton Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Eton Pharmaceuticals, ANI Pharmaceuticals Launch Carglumic Acid Tablets for Hyperammonemia

12/20/2021 | 10:44am EDT


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
ANI PHARMACEUTICALS, INC. 3.14% 30.86 Delayed Quote.-33.03%
ETON PHARMACEUTICALS, INC. 2.19% 3.26 Delayed Quote.-24.01%
RECORDATI 2.53% 42.56 Delayed Quote.-24.67%
All news about ETON PHARMACEUTICALS, INC.
05/12TRANSCRIPT : Eton Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 12, 2022
CI
05/12ETON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition..
AQ
05/12Eton Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 3..
CI
05/12Earnings Flash (ETON) ETON PHARMACEUTICALS Reports Q1 Revenue $2.2M
MT
05/12Eton Pharmaceuticals Reports First Quarter 2022 Financial Results
GL
05/12Eton Pharmaceuticals Reports First Quarter 2022 Financial Results
AQ
05/12Eton Pharmaceuticals, Inc. Provides Revenue Guidance for the Full Year 2022
CI
05/03Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12..
GL
05/03Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12..
AQ
04/11ETON PHARMACEUTICALS : Appoints James Gruber as Chief Financial Officer - Form 8-K
PU
More news
Analyst Recommendations on ETON PHARMACEUTICALS, INC.
More recommendations
Financials (USD)
Sales 2022 30,7 M - -
Net income 2022 -1,18 M - -
Net Debt 2022 - - -
P/E ratio 2022 -72,4x
Yield 2022 -
Capitalization 82,2 M 82,2 M -
Capi. / Sales 2022 2,68x
Capi. / Sales 2023 1,53x
Nbr of Employees 17
Free-Float 80,1%
Chart ETON PHARMACEUTICALS, INC.
Duration : Period :
Eton Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ETON PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 3,26 $
Average target price 10,50 $
Spread / Average Target 222%
EPS Revisions
Managers and Directors
Sean E. Brynjelsen President, Chief Executive Officer & Director
James Gruber Chief Financial Officer
Norbert G. Riedel Chairman
Charles J. Casamento Independent Director
Paul Victor Maier Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ETON PHARMACEUTICALS, INC.-24.01%82
MERCK KGAA-24.05%79 076
KYOWA KIRIN CO. LTD.-13.65%11 377
SK BIOPHARMACEUTICALS CO., LTD.-11.21%5 308
YUHAN CORPORATION-5.80%3 126
BETTA PHARMACEUTICALS CO., LTD.-43.32%2 808